LF

Lili Feng

NA Novartis Ag: 10 patents #339 of 5,128Top 7%
NP Novartis Pharmaceuticals: 3 patents #4 of 44Top 10%
SR Scripps Research: 2 patents #437 of 1,293Top 35%
📍 Pine Brook, NJ: #6 of 64 inventorsTop 10%
🗺 New Jersey: #5,727 of 69,400 inventorsTop 9%
Overall (All Time): #314,831 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
11642329 Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations Sven Erik Godtfredsen, Paul Allen Sutton, Mahavir Prashad, Michael John Girgis, Bin Hu +3 more 2023-05-09
RE49080 Glycoside derivatives and uses thereof Gregory Raymond Bebernitz, Mark G. Bock, Dumbala Srinivas Reddy, Atul Kashinath Hajare, Vinod Vyavahare +7 more 2022-05-24
11096918 Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations Sven Erik Godtfredsen, Paul Allen Sutton, Mahavir Prashad, Michael John Girgis, Bin Hu +3 more 2021-08-24
10093665 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein Jeewan Thakur, Dong Yang 2018-10-09
9895389 Glycoside derivatives and uses thereof Gregory Raymond Bebernitz, Mark G. Bock, Dumbala Srinivas Reddy, Atul Kashinath Hajare, Vinod Vyavahare +7 more 2018-02-20
9540363 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein Jeewan Thakur, Dong Yang 2017-01-10
9388134 Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations Sven Erik Godtfredsen, Paul Allen Sutton, Mahavir Prashad, Michael John Girgis, Bin Hu +3 more 2016-07-12
9309229 Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine Baoqing Gong, Piotr H. Karpinski, Liladhar Murlidhar Waykole 2016-04-12
8877938 Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cations Sven Erik Godtfredsen, Bin Hu, Yugang Liu, Piotr H. Karpinski, Paul Allen Sutton +3 more 2014-11-04
8828951 Glycoside derivatives and uses thereof Gregory Raymond Bebernitz, Mark G. Bock, Dumbala Srinivas Reddy, Atul Kashinath Hajare, Vinod Vyavahare +7 more 2014-09-09
8623385 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein Jeewan Thakur, Dong Yang 2014-01-07
8466114 Glycoside derivatives and uses thereof Gregory Raymond Bebernitz, Mark G. Bock, Dumbala Srinivas Reddy, Atul Kashinath Hajare, Vinod Vyavahare +7 more 2013-06-18
8163704 Glycoside derivatives and uses thereof Gregory Raymond Bebernitz, Mark G. Bock, Dumbala Srinivas Reddy, Atul Kashinath Hajare, Vinod Vyavahare +7 more 2012-04-24
7067472 Diagnostic and therapeutic methods related to regulating energy mobilization with OB protein and OB antibodies Shizhong Chen, YIYANG XIA 2006-06-27
5731343 Method of use of radicicol for treatment of immunopathological disorders Daniel Hwang 1998-03-24